Recombinant Fusion Proteins
"Recombinant Fusion Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.
| Descriptor ID |
D011993
|
| MeSH Number(s) |
D12.776.828.300
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Fusion Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Fusion Proteins".
This graph shows the total number of publications written about "Recombinant Fusion Proteins" by people in this website by year, and whether "Recombinant Fusion Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 13 | 16 |
| 1997 | 1 | 20 | 21 |
| 1998 | 2 | 15 | 17 |
| 1999 | 1 | 16 | 17 |
| 2000 | 1 | 18 | 19 |
| 2001 | 4 | 24 | 28 |
| 2002 | 5 | 23 | 28 |
| 2003 | 4 | 19 | 23 |
| 2004 | 2 | 21 | 23 |
| 2005 | 1 | 18 | 19 |
| 2006 | 2 | 11 | 13 |
| 2007 | 2 | 13 | 15 |
| 2008 | 0 | 8 | 8 |
| 2009 | 5 | 26 | 31 |
| 2010 | 3 | 12 | 15 |
| 2011 | 11 | 17 | 28 |
| 2012 | 3 | 11 | 14 |
| 2013 | 4 | 11 | 15 |
| 2014 | 3 | 10 | 13 |
| 2015 | 4 | 5 | 9 |
| 2016 | 2 | 7 | 9 |
| 2017 | 8 | 13 | 21 |
| 2018 | 5 | 3 | 8 |
| 2019 | 1 | 3 | 4 |
| 2020 | 4 | 1 | 5 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 6 | 6 |
| 2023 | 2 | 3 | 5 |
| 2024 | 0 | 3 | 3 |
| 2025 | 3 | 1 | 4 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinant Fusion Proteins" by people in Profiles.
-
Peri-Event Intravitreal Anti-VEGF and Systemic Outcomes After Stroke or Myocardial Infarction. JAMA Ophthalmol. 2026 05 01; 144(5):415-422.
-
Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study. Ophthalmology. 2026 Jul; 133(7):837-851.
-
Summary of Research: Risdiplam Treatment Following Onasemnogene Abeparvovec in Individuals with Spinal Muscular Atrophy: A Multicenter Case Series. Adv Ther. 2026 Apr; 43(4):1380-1383.
-
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series. BMC Neurol. 2025 Jul 07; 25(1):283.
-
Characteristic profiling of CHO-cell expressed MERS-CoV RBD-Fc. Int J Biol Macromol. 2025 Jun; 311(Pt 2):143678.
-
Sialidase fusion protein protects against influenza infection in a cigarette smoke-induced model of COPD. Mucosal Immunol. 2025 Apr; 18(2):467-480.
-
Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 11; 31(11-12):587-593.
-
A method for rapid and reliable quantification of VEGF-cell binding activity. Biochem Biophys Res Commun. 2024 10 01; 727:150321.
-
An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine. 2024 09 17; 42(22):125909.
-
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2023 12 14; 389(24):2256-2266.